Biodue
Biodue S.p.A. is an Italian CDMO founded in 1986 that develops, manufactures, and packages food supplements, medical devices, and cosmetics for European pharmaceutical, nutraceutical, and consumer healthcare clients under long-term manufacturing agreements.
- Company typePrivate
- Founded1986
- HeadquartersSambuca, Italy
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Biodue firmographics
Firmographics- Name
- Biodue
- Legal name
- BioDue S.p.A.
- Website
- https://biodue.com
- Company type
- Private
- Founded year
- 1986
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Biodue S.p.A. is an Italian CDMO founded in 1986 that develops, manufactures, and packages food supplements, medical devices, and cosmetics for European pharmaceutical, nutraceutical, and consumer healthcare clients under long-term manufacturing agreements.
- Ownership category
- akta.pro rank
Biodue industry classification
Industry- Product category
- Contract Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
- akta.pro secondary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
Keywords
Where Biodue is headquartered
LocationHeadquarters
- HQ city
- Sambuca
- HQ country
- Italy
- HQ region
- Europe
Offices6 records
Markets served
Biodue business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- CDMO Manufacturing Services: Contract development and manufacturing organization providing full-service B2B offerings including raw material sourcing, development and formulation, production, packaging, regulatory affairs, and commercialization of food supplements, medical devices, and cosmetics. Revenue generated through long-term manufacturing agreements and exclusive production contracts with clients.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Biodue product offering
Product offeringCore offering
Biodue is an Italian Contract Development and Manufacturing Organization (CDMO) that produces food supplements, medical devices, and cosmetics for third-party brands. The company operates seven manufacturing plants with more than 100 production lines and serves clients across 30 countries. Its offering combines R&D, formulation development, manufacturing, packaging, and regulatory support under proprietary platforms such as Caps in Caps technology.
Product overview
Biodue is an Italian CDMO (Contract Development and Manufacturing Organization) founded in 1986 that provides integrated manufacturing services for the health care sector. The company operates through three core product categories—Food Supplements, Medical Devices, and Cosmetics—supported by its proprietary Caps in Caps technology for advanced oral dosage delivery. Its offering spans the entire product lifecycle from R&D and formulation development through production and packaging to regulatory affairs and commercialization. Biodue is part of the Healthea Group and serves both large pharma and nutraceutical companies as well as niche operators across Europe.
Differentiator
Problem solved
Functional benefit
Brands
- Farcoderma: Part of Healthea Group portfolio of companies, focused on health care products manufacturing.
- Healthea Group
- Caps in Caps
Products and services
- Food Supplement Manufacturing
Companies that use Biodue
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles1 record
Biodue technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Biodue partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Venture Life Group plc (VLG)coreUK-quoted consumer healthcare group from which BioDue acquired CDMO business unit including Biokosmes and Rolf Kullgren brands. At closing, VLG enters into a long-term manufacturing agreement with BioDue for exclusive production of its products. Approximately 70% of the acquired business unit's sales come from medical devices, complementing BioDue's traditional focus on food supplements.
- BMG PharmaminorItalian B2B company carved out from BioDue under Riverside ownership, focused on development and out-licensing of innovative patented products for oral health, dermatology, and broader nutraceutical industry.
- Healthea GroupcoreGroup of companies founded in 2025 with the aim of bringing together the best CDMOs in Europe under a single brand. BioDue is a founding member, along with FARCOS and other entities. The group provides one of the widest commercial offers in the healthcare sector on the European market.
Scale indicators8 records
Recent moves3 records
Expansion highlights6 records
Biodue competitors and assessment
Company assessmentDirect peers
- Delpharm: French-headquartered European CDMO providing contract development and manufacturing for pharma and consumer health. Comparable as a multi-site European CDMO serving brand-owner clients, with similar B2B service orientation.
- Fareva: European CDMO offering contract manufacturing for pharmaceuticals, cosmetics, and FMCG. Highly comparable to Biodue in product category breadth (pharma, cosmetics, consumer health), B2B service model, and mid-market European positioning.
- Recipharm: Swedish-headquartered CDMO with multiple European manufacturing sites serving pharma and consumer health clients. Comparable as a multi-site European contract manufacturer, though with a stronger prescription-pharma tilt than Biodue's nutraceutical-heavy mix.
- Sirio Pharma: CDMO specializing in nutraceuticals and consumer health products, including gummies, softgels, and capsules. Comparable as a dedicated nutraceutical CDMO with proprietary delivery formats, directly overlapping with Biodue's food supplement focus and Caps in Caps positioning.
- Aenova Group: European CDMO focused on solid oral dosage forms, semi-solids, and sterile fill-finish for pharma and consumer health. Comparable in CDMO service model, European footprint, and diversified dosage-form capabilities similar to Biodue's broad pharmaceutical-form portfolio.
Broad incumbents
- Lonza Group: Global CDMO leader in API, biologics, and cell & gene therapy manufacturing. Comparable as a CDMO, but with a far larger and more biotech-oriented portfolio than Biodue's nutraceutical, medical-device, and cosmetics mix.
- Catalent: Global large-cap CDMO with extensive softgel, oral, sterile, and biologics capabilities. Comparable in CDMO service model and dosage-form breadth, but operates at a much larger scale and across broader therapeutic and biologics categories than Biodue.
- CordenPharma: International CDMO providing API, drug product, and packaging services across multiple dosage forms. Comparable in integrated CDMO model and European roots, though focused more on prescription pharma than consumer health.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Biodue social profiles
Digital presenceBiodue compliance and trust
Trust signalCompliance5 records
Biodue financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biodue leadership team
Management profileNumber of profiles
Profiles1 record
Biodue subsidiaries and ownership
Company hierarchySubsidiaries3 records
Biodue funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biodue M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biodue
What does Biodue do?
Biodue is an Italian Contract Development and Manufacturing Organization (CDMO) that produces food supplements, medical devices, and cosmetics for third-party brands. The company operates seven manufacturing plants with more than 100 production lines and serves clients across 30 countries. Its offering combines R&D, formulation development, manufacturing, packaging, and regulatory support under proprietary platforms such as Caps in Caps technology.
Is Biodue a public or private company?
Biodue is a private company. It is classified as private equity controlled and is currently operating.
When was Biodue founded?
Biodue was founded in 1986. It employs 101 to 250 people.
Where is Biodue based?
Biodue is headquartered in Sambuca, Italy, in the Europe region.
How does Biodue make money?
One revenue line is on record: CDMO Manufacturing Services.
Who are Biodue's main competitors?
Direct peers on record are Delpharm, Fareva, Recipharm, Sirio Pharma and Aenova Group. Broad incumbents are Lonza Group, Catalent and CordenPharma.
Does Biodue have an API?
No public API is recorded for Biodue.
What industry is Biodue in?
Biodue's product category is Contract Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO. Its NAICS code is 325412 and its SIC code is 2834.